Inventor · disambiguated record
Xiaowen He
Also filed as: HE XIAOWEN
6 granted patents·10 pending applications·23 citations·filing 2004–2024
74Inventor score
Top patents by PatentIndex Score
16 records- 0183US9418101B2Query optimizationHE XIAOWEN·Filed 2012·Granted Aug 16, 2016·13 cites·18 claims
- 0274US12479921B2Anti-PD-L1 antibody and use thereofORICELL THERAPEUTICS CO LTD·Filed 2024·Granted Nov 25, 2025·0 cites·12 claims
- 0363US2024400989A1Method for promoting proliferation of immune cellsORICELL THERAPEUTICS CO LTD·Filed 2024·Application pending·0 cites
- 0461US7296040B2System and method of formulating queries in relational databasesCOGNOS INC·Filed 2004·Granted Nov 13, 2007·10 cites·3 claims
- 0559US2025057950A1Chimeric antigen receptor targeting gprc5d and application thereofORICELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0657US2023276817A1PREPARATION AND METHOD FOR IMPROVING RiNG ROT RESISTANCE OF APPLE FRUITSSHANDONG INST POMOLOGY·Filed 2022·Application pending·0 cites
- 0757US2024384001A1Anti-gprc5d antigen binding protein and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0856US2025213691A1Antigen binding protein targeting msln and use thereofORICELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0952US2025177527A1Chimeric antigen receptor targeting cldn18.2 and msln and use thereofORICELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 1049US11993655B2Anti-PD-L1 antibody and use thereofORICELL THERAPEUTICS CO LTD·Filed 2018·Granted May 28, 2024·0 cites·18 claims
- 1149US2024182562A1Cldn18.2 antigen-binding protein and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1249US2024383992A1Bcma-targeting chimeric antigen receptor and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1348US2024366672A1Chimeric antigen receptor and use thereofORICELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1446US12054556B2Anti-PD-L1 antibody and use thereofORICELL THERAPEUTICS CO LTD·Filed 2021·Granted Aug 6, 2024·0 cites·13 claims
- 1541US2022389076A1Modified immune cell and use thereofORICELL THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1640US12005080B2Method for promoting proliferation of immune cellsORICELL THERAPEUTICS CO LTD·Filed 2019·Granted Jun 11, 2024·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →